08/06/2025
11:14 AM | FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SCHEDULE 13G/A | |
08/01/2025
3:01 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2025
3:04 PM | Jover Placid (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2025
6:06 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2025
8:25 AM | Phoenix Financial Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SCHEDULE 13G | |
07/17/2025
10:57 AM | MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SCHEDULE 13G | |
06/09/2025
3:15 PM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:18 PM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:22 PM | Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:25 PM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TEVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. |
06/05/2025
3:52 PM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2025
3:16 PM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
4:13 PM | Teva Pharmaceutical Industries (Subject)
| Form FWP | |
05/19/2025
5:50 AM | Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Finance Netherlands IV B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
| Form 424B5 | |
05/08/2025
1:34 PM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form DEF 14A | |
04/07/2025
3:01 PM | Lippman Evan (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2025
3:22 PM | McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:25 PM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:29 PM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:13 PM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:16 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:19 PM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:06 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:08 PM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:11 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:13 PM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:29 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
3:08 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:14 PM | McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
03/04/2025
5:57 PM | McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:02 PM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
5:30 PM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
5:37 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
5:44 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
12:07 PM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
11:59 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
12:14 PM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
10:52 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
02/18/2025
11:38 AM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
7:06 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
3:06 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
6:03 PM | BRIDGER MANAGEMENT, LLC (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
3:04 PM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
10:39 AM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G | |
11/06/2024
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
6:40 AM | Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:06 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/14/2024
5:24 AM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/12/2024
3:09 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access Sale